Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-10-16
2010-06-22
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S262000
Reexamination Certificate
active
07741330
ABSTRACT:
Described herein are kinase inhibitor compounds, methods for synthesizing such inhibitors, and methods for using such inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate inhibitor of a protein, including a kinase.
REFERENCES:
patent: 6660744 (2003-12-01), Hirst et al.
patent: 6921763 (2005-07-01), Hirst et al.
patent: 7332497 (2008-02-01), Hirst et al.
patent: 7514444 (2009-04-01), Honigberg et al.
patent: 2008/0076921 (2008-03-01), Honigberg et al.
patent: 2008/0139582 (2008-06-01), Honigberg et al.
patent: 2009/0181987 (2009-07-01), Honigberg et al.
Chen Wei
Loury David J.
Mody Tarak D.
Moore Susanna
Pharmacyclics Inc.
Wilson Sonsini Goodrich & Rosati
LandOfFree
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4217731